What is the Org number of UroMedical Väst AB?

UroMedical Väst AB is registered with Bolagsverket / SCB under Org 5590271846.

What is the revenue of UroMedical Väst AB?

UroMedical Väst AB reported revenue of SEK 53,4M in 2025.

UroMedical Väst AB employs 15 people as of the latest annual report.

Anna Maria Kristina Frånlund is the CEO of UroMedical Väst AB, in role since 2024.

Jonathan Kimber chairs the board of UroMedical Väst AB, in role since 2025.

UroMedical Väst AB's registered address is Carlanderska Sjukhuset.

ABActive

Org 5590271846Carlanderska Sjukhuset, 405 45 GöteborgHospital activities· NACE 8610Est. 2015 · 10 years old15 employees

Actively employed in the business

Name	Role	Member since
Current (2)
KK Karin Kristina Eriksson Chief Auditor	Chief Auditor	2020
AM Anna Maria Kristina Frånlund Chief Executive Officer	Chief Executive Officer	2024
Former (1)
BP Börje Patrik Lennart Andius Chief Executive Officer	Chief Executive Officer	2020 – 2022

Non-executive oversight

Name	Role	Member since
Current (4)
ER Erik Rönnblad Board of Directors	Board of Directors	2026
AU Anna Ulrika Hansson Board of Directors	Board of Directors	2024
JW Jan-Olof Wiklund Deputy Board Member	Deputy Board Member	2024
JK Jonathan Kimber Chairman	Chairman	2025
Former (8)
TH Thomas Haugen Skorpen Board of Directors	Board of Directors	2023 – 2023
ØB Øyvind Bakke Board of Directors	Board of Directors	2020 – 2024
GL Gard Lauvsnes Board of Directors	Board of Directors	2020 – 2022
FR Fred Rosendal Helgesen Chairman	Chairman	2024 – 2025
MH Morten Henrik Greidung Chairman	Chairman	2020 – 2022
PB Patrik Bø Egeland Chairman	Chairman	2022 – 2023
RG Robert Gelmanovski Chairman	Chairman	2022 – 2022
KJ Kurt Jonas Einar Hugosson Board of Directors	Board of Directors	2020 – 2024

As of last annual report

Shareholder	Type	Ownership	Votes	Since
UroMedical BidCo AB	Company	100%	100%	2025
C-Medical Sverige AB	Company	100%	100%	0001

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.